Luvox and Oesophagitis aggravated - a phase IV clinical study of FDA data

Summary:

Oesophagitis aggravated is reported as a side effect among people who take Luvox (fluvoxamine maleate), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Atenolol, and have Gastritis.

The phase IV clinical study analyzes which people have Oesophagitis aggravated when taking Luvox. It is created by eHealthMe based on reports of 12,486 people who have side effects when taking Luvox from the FDA, and is updated regularly.

What is Luvox?

Luvox has active ingredients of fluvoxamine maleate. It is often used in obsessive-compulsive disorder. eHealthMe is studying from 13,439 Luvox users. Check the latest studies of Luvox.

What is Oesophagitis aggravated?

Oesophagitis aggravated (inflammation of oesophagus) is found to be associated with 970 drugs and 378 conditions by eHealthMe. Check the latest studies of Oesophagitis aggravated.

On Jul, 15, 2026

12,486 people reported to have side effects when taking Luvox.
Among them, 12 people (0.1%) have Oesophagitis aggravated.

Could Luvox cause Oesophagitis aggravated?

Among these 12 people:

How long have people been on Luvox when they have Oesophagitis aggravated? *

What is the gender of people who have Oesophagitis aggravated when taking Luvox? *

female: 75 %
male: 25 %

What is the age of people who have Oesophagitis aggravated when taking Luvox? *

What are other drugs people take besides Luvox? *

What are other side effects people have besides Oesophagitis aggravated? *

Weakness: 3 people, 25.00%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 3 people, 25.00%
Gastric Ulcer (stomach ulcer): 3 people, 25.00%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 2 people, 16.67%
Glossodynia (a burning or painful sensation in the tongue): 2 people, 16.67%
Gastritis (inflammation of stomach): 2 people, 16.67%
Haematemesis (vomiting of blood): 2 people, 16.67%
Drug Ineffective: 2 people, 16.67%
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight): 2 people, 16.67%
Radiation Pneumonitis (inflammation of lung due to radiation): 2 people, 16.67%

What are the existing conditions these people have? *

Prostate Cancer: 1 person, 8.33%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 8.33%
Gastritis (inflammation of stomach): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Luvox and have Oesophagitis aggravated?

- Check whether Oesophagitis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Luvox:

Luvox (13,439 reports)

Browse all side effects of Luvox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Oesophagitis aggravated:

Oesophagitis aggravated (970 drugs)

Browse all the conditions that are associated with Oesophagitis aggravated:

Oesophagitis aggravated (378 conditions)

Related publications that referenced our studies

Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on fluvoxamine maleate (the active ingredients of Luvox) and Luvox (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.